Koyfin Home > Directory > Health Care > Incyte Corp > EBIT

Incyte Corp EBIT Chart (INCY)

Incyte Corp annual/quarterly EBIT from 1993 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Incyte Corp EBIT for the quarter ending December 12, 2018 was $89m a 167.56% increase of 150m year over year
  • Incyte Corp EBIT for the last 12 months ending December 12, 2018 was $155m a 202.04% increase of 314m year over year
  • Incyte Corp Annual EBIT for 2018 was $155m a 244.17% increase of 379m from 2017
  • Incyte Corp Annual EBIT for 2017 was $-224m a 173.21% decrease of -388m from 2016
  • Incyte Corp Annual EBIT for 2016 was $164m a 69.12% increase of 113m from 2015
Other Income Statement Metrics:
  • Incyte Corp EBITDA for the quarter ending December 12, 2018 was $103m a 145.94% increase of 150m year over year
  • Incyte Corp Net Income for the quarter ending December 12, 2018 was $69m a 159.57% increase of 110m year over year
  • Incyte Corp Total Revenue for the quarter ending December 12, 2018 was $528m a 27.65% increase of 146m year over year
View Chart On Koyfin

Quarterly INCY EBIT Data

12/2018$89m
09/2018$36m
06/2018$90m
03/2018$-60m
12/2017$-123m
09/2017$11m
06/2017$14m
03/2017$-126m
12/2016$51m
09/2016$30m

Annual INCY EBIT Data

2018$155m
2017$-224m
2016$164m
2015$51m
2014$-5m
2013$-16m
2012$1m
2011$-142m
2010$14m
2009$-138m